Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Lu

Showing results (581-590 of 972) with videos related to

Pageof 98
Sort By:
Breast Cancer Research : BCR|March 17, 2016
Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancerIan E Krop, Shanu Modi, Patricia M LoRusso, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 12, 2024
Low Muscle Mass is Independently Associated with an Increased Risk of Having Lower Limb Atherosclerosis in T2DM PatientsSijie Deng, Shishi Lv, Yiying Liu, et al.
Cell Death & Disease|October 13, 2023
Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney diseaseWenyan Hao, Hongxian Zhang, Peng Hong, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 13, 2020
MiR-199a-5p Targets ZEB1 to Inhibit the Epithelial-Mesenchymal Transition of Ovarian Ectopic Endometrial Stromal Cells Via PI3K/Akt/mTOR Signal Pathway In Vitro and In VivoYong Liu, Chang Lu, Linyuan Fan, et al.
Molecular Neurobiology|October 20, 2020
Long Non-coding RNA MALAT1 Upregulates ZEB2 Expression to Promote Malignant Progression of Glioma by Attenuating miR-124Hongyu Cheng, Haikang Zhao, Xin Xiao, et al.
International Journal of Pediatric Otorhinolaryngology|December 31, 2017
Adaptation and validation of Mandarin Chinese version of the pediatric Voice Handicap Index (pVHI)Dan Lu, Mengjie Huang, Zhen Li, et al.
Acta Pharmacologica Sinica|September 27, 2019
ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replicationZi-Yu Wang, Yu-Qi Li, Zhi-Wei Guo, et al.
Gynecologic Oncology|June 28, 2011
Comparison of candidate serologic markers for type I and type II ovarian cancerDan Lu, Elisabetta Kuhn, Robert E Bristow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
The tumor-suppressive function of UNC5D and its repressed expression in renal cell carcinomaDan Lu, Dong Dong, Yu Zhou, et al.
The Journal of Cell Biology|October 8, 2014
Multiple mechanisms determine the order of APC/C substrate degradation in mitosisDan Lu, Jennifer Y Hsiao, Norman E Davey, et al.
Pageof 98

Showing results (581-590 of 972) with videos related to

Sort By:
Pageof 98
Breast Cancer Research : BCR|March 17, 2016
Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancerIan E Krop, Shanu Modi, Patricia M LoRusso, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 12, 2024
Low Muscle Mass is Independently Associated with an Increased Risk of Having Lower Limb Atherosclerosis in T2DM PatientsSijie Deng, Shishi Lv, Yiying Liu, et al.
Cell Death & Disease|October 13, 2023
Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney diseaseWenyan Hao, Hongxian Zhang, Peng Hong, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|February 13, 2020
MiR-199a-5p Targets ZEB1 to Inhibit the Epithelial-Mesenchymal Transition of Ovarian Ectopic Endometrial Stromal Cells Via PI3K/Akt/mTOR Signal Pathway In Vitro and In VivoYong Liu, Chang Lu, Linyuan Fan, et al.
Molecular Neurobiology|October 20, 2020
Long Non-coding RNA MALAT1 Upregulates ZEB2 Expression to Promote Malignant Progression of Glioma by Attenuating miR-124Hongyu Cheng, Haikang Zhao, Xin Xiao, et al.
International Journal of Pediatric Otorhinolaryngology|December 31, 2017
Adaptation and validation of Mandarin Chinese version of the pediatric Voice Handicap Index (pVHI)Dan Lu, Mengjie Huang, Zhen Li, et al.
Acta Pharmacologica Sinica|September 27, 2019
ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replicationZi-Yu Wang, Yu-Qi Li, Zhi-Wei Guo, et al.
Gynecologic Oncology|June 28, 2011
Comparison of candidate serologic markers for type I and type II ovarian cancerDan Lu, Elisabetta Kuhn, Robert E Bristow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
The tumor-suppressive function of UNC5D and its repressed expression in renal cell carcinomaDan Lu, Dong Dong, Yu Zhou, et al.
The Journal of Cell Biology|October 8, 2014
Multiple mechanisms determine the order of APC/C substrate degradation in mitosisDan Lu, Jennifer Y Hsiao, Norman E Davey, et al.
Pageof 98